BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
7.6200
10-January-25 13:34:51
15 minutes delayed
Stocks
-0.4300
-5.34%
Today's range
7.5300 - 8.4900
ISIN
N/A
Source
NASDAQ
-
BioCryst to Present at Upcoming Investor Conferences
01 Jun 2022 07:00:15 By Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
06 May 2022 07:00:28 By Nasdaq GlobeNewswire
-
BioCryst Reports First Quarter 2022 Financial Results and Upcoming Key Milestones
05 May 2022 07:00:11 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 May 2022 16:15:39 By Nasdaq GlobeNewswire
-
27 Apr 2022 07:00:00 By Nasdaq GlobeNewswire
-
BioCryst to Report First Quarter 2022 Financial Results on May 5
21 Apr 2022 07:00:52 By Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conference
11 Apr 2022 08:30:49 By Nasdaq GlobeNewswire
-
BioCryst Pauses Enrollment in BCX9930 Clinical Trials
08 Apr 2022 09:15:13 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Apr 2022 07:15:42 By Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
03 Mar 2022 07:00:01 By Nasdaq GlobeNewswire